Skip to main content

Advertisement

Log in

Moderate-severe grade of chronic graft versus host disease and younger age (less than 45 years old) are risk factors for avascular necrosis in adult patients undergoing allogeneic hematopoietic cell transplantation

  • Original Article
  • Published:
Annals of Hematology Aims and scope Submit manuscript

Abstract

Avascular necrosis (AVN) is a debilitating complication of allogeneic hematopoietic cell transplantation (HCT). A retrospective review of 845 patients who underwent HCT was conducted. Cumulative incidence of AVN was 6.3% at 4 years. The following risk factors were significantly associated with AVN risk on univariate analysis: age < 45 (p=0.004), moderate to severe chronic GvHD (p<0.001), reduced intensity conditioning (p=0.02), and a diagnosis of acute leukemia (p=0.045). Multivariate analysis confirmed two risk factors: younger age (<45 years), 9.0% vs 4.4% (p=0.011, hazard ratio (HR) 2.134), and moderate-severe chronic GvHD, 15.4% vs 2.1% (p<0.001, HR 4.950). A risk score model was generated assigning a score to each risk factor. A score of 1 was assigned to moderate-severe GvHD or those with age <45. Total score was calculated, thus dividing patient into three groups: low (score 0, n=349, 41.3%), intermediate (score 1, n=379, 44.9%), and high risk (score 2; n=116, 13.7%). This risk score could stratify the patients according to AVN risk (p<0.001). The risk of AVN was 1.5% in the low risk, 6.2% in the intermediate risk, and 20.8% in the high risk groups. Moderate-severe chronic GvHD and younger age (<45 years) are key risk factors for AVN following allogeneic HCT.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Socie G, Cahn JY, Carmelo J et al (1997) Avascular necrosis of bone after allogeneic bone marrow transplantation: analysis of risk factors for 4388 patients by the Societe Francaise de Greffe de Moelle (SFGM). Br J Haematol 97:865–870

    Article  CAS  PubMed  Google Scholar 

  2. Li X, Brazauskas R, Wang Z, al-Seraihy A, Baker KS, Cahn JY, Frangoul HA, Gajewski JL, Hale GA, Hsu JW, Kamble RT, Lazarus HM, Marks DI, Maziarz RT, Savani BN, Shah AJ, Shah N, Sorror ML, Wood WA, Majhail NS (2014) Avascular necrosis of bone after allogeneic hematopoietic cell transplantation in children and adolescents. Biol Blood Marrow Transplant 20:587–592

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. McAvoy S, Baker KS, Mulrooney D, Blaes A, Arora M, Burns LJ, Majhail NS (2010) Corticosteroid dose as a risk factor for avascular necrosis of the bone after hematopoietic cell transplantation. Biol Blood Marrow Transplant 16:1231–1236

    Article  CAS  PubMed  Google Scholar 

  4. Campbell S, Sun CL, Kurian S, Francisco L, Carter A, Kulkarni S, Parker P, Karanes C, Forman SJ, Bhatia S (2009) Predictors of avascular necrosis of bone in long-term survivors of hematopoietic cell transplantation. Cancer 115:4127–4135

    Article  PubMed  Google Scholar 

  5. Kim DH, Jamal N, Saragosa R, Loach D, Wright J, Gupta V, Kuruvilla J, Lipton JH, Minden M, Messner HA (2007) Similar outcomes of cryopreserved allogeneic peripheral stem cell transplants (PBSCT) compared to fresh allografts. Biol Blood Marrow Transplant 13:1233–1243

    Article  CAS  PubMed  Google Scholar 

  6. Enright H, Haake R, Weisdorf D (1990) Avascular necrosis of bone: a common serious complication of allogeneic bone marrow transplantation. Am J Med 89:733–738

    Article  CAS  PubMed  Google Scholar 

  7. Schulte C, Beelen DW, Schaefer UW, Mann K (2000) Bone loss in long-term survivors after transplantation of hematopoietic stem cells: a prospective study. Osteoporos Int 11:344–353

    Article  CAS  PubMed  Google Scholar 

  8. Schulte CM, Beelen DW (2004) Avascular osteonecrosis after allogeneic hematopoietic stem-cell transplantation: diagnosis and gender matter. Transplantation 78:1055–1063

    Article  PubMed  Google Scholar 

  9. Wiesmann A, Pereira P, Bohm P et al (1998) Avascular necrosis of bone following allogeneic stem cell transplantation: MR screening and therapeutic options. Bone Marrow Transplant 22:565–569

    Article  CAS  PubMed  Google Scholar 

  10. Socie G, Selimi F, Sedel L et al (1994) Avascular necrosis of bone after allogeneic bone marrow transplantation: clinical findings, incidence and risk factors. Br J Haematol 86:624–628

    Article  CAS  PubMed  Google Scholar 

  11. Tauchmanova L, De Rosa G, Serio B et al (2003) Avascular necrosis in long-term survivors after allogeneic or autologous stem cell transplantation: a single center experience and a review. Cancer 97:2453–2461

    Article  PubMed  Google Scholar 

  12. Carpenter PA (2008) Late effects of chronic graft-versus-host disease. Best Pract Res Clin Haematol 21:309–331

    Article  PubMed  Google Scholar 

  13. Mascarin M, Giavitto M, Zanazzo GA, Andolina M, Tamaro P, Cova M, Accorsi E (1991) Avascular necrosis of bone in children undergoing allogeneic bone marrow transplantation. Cancer 68:655–659

    Article  CAS  PubMed  Google Scholar 

  14. Jagasia MH, Greinix HT, Arora M, Williams KM, Wolff D, Cowen EW, Palmer J, Weisdorf D, Treister NS, Cheng GS, Kerr H, Stratton P, Duarte RF, McDonald GB, Inamoto Y, Vigorito A, Arai S, Datiles MB, Jacobsohn D, Heller T, Kitko CL, Mitchell SA, Martin PJ, Shulman H, Wu RS, Cutler CS, Vogelsang GB, Lee SJ, Pavletic SZ, Flowers MED (2015) National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report. Biol Blood Marrow Transplant 21:389–401 e381

    Article  PubMed  Google Scholar 

  15. Gupta V, Daly A, Lipton JH, Hasegawa W, Chun K, Kamel-Reid S, Tsang R, Yi QL, Minden M, Messner H, Kiss T (2005) Nonmyeloablative stem cell transplantation for myelodysplastic syndrome or acute myeloid leukemia in patients 60 years or older. Biol Blood Marrow Transplant 11:764–772

    Article  PubMed  Google Scholar 

  16. Kim DH, Messner H, Minden M, Gupta V, Kuruvilla J, Wright J, Lipton J (2008) Factors influencing varicella zoster virus infection after allogeneic peripheral blood stem cell transplantation: low-dose acyclovir prophylaxis and pre-transplant diagnosis of lymphoproliferative disorders. Transpl Infect Dis 10:90–98

    Article  CAS  PubMed  Google Scholar 

  17. Kiss TL, Panzarella T, Messner HA, Meharchand J, Reddy V, Schimmer AD, Lipton JH (2003) Busulfan and cyclophosphamide as a preparative regimen for allogeneic blood and marrow transplantation in patients with non-Hodgkin's lymphoma. Bone Marrow Transplant 31:73–78

    Article  CAS  PubMed  Google Scholar 

  18. Messner HA (2002) Long-term outcome of allogeneic transplants in acute myeloid leukemia. Leukemia 16:751–752

    Article  CAS  PubMed  Google Scholar 

  19. Pond GR, Lipton JH, Messner HA (2006) Long-term survival after blood and marrow transplantation: comparison with an age- and gender-matched normative population. Biol Blood Marrow Transplant 12:422–429

    Article  PubMed  Google Scholar 

  20. Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J, Thomas ED (1995) 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant 15:825–828

    CAS  PubMed  Google Scholar 

  21. Shulman HM, Sullivan KM, Weiden PL, McDonald GB, Striker GE, Sale GE, Hackman R, Tsoi MS, Storb R, Donnall Thomas E (1980) Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med 69:204–217

    Article  CAS  PubMed  Google Scholar 

  22. Visentin S, Auquier P, Bertrand Y, Baruchel A, Tabone MD, Pochon C, Jubert C, Poirée M, Gandemer V, Sirvent A, Bonneau J, Paillard C, Freycon C, Kanold J, Villes V, Berbis J, Oudin C, Galambrun C, Pellier I, Plat G, Chambost H, Leverger G, Dalle JH, Michel G (2016) The Impact of Donor Type on Long-Term Health Status and Quality of Life after Allogeneic Hematopoietic Stem Cell Transplantation for Childhood Acute Leukemia: A Leucemie de l'Enfant et de L'Adolescent Study. Biol Blood Marrow Transplant 22:2003–2010

    Article  PubMed  Google Scholar 

  23. Miklos D, Cutler CS, Arora M, Waller EK, Jagasia M, Pusic I, Flowers ME, Logan AC, Nakamura R, Blazar BR, Li Y, Chang S, Lal I, Dubovsky J, James DF, Styles L, Jaglowski S (2017) Ibrutinib for chronic graft-versus-host disease after failure of prior therapy. Blood 130:2243–2250

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Kaste SC, Pei D, Cheng C, Neel MD, Bowman WP, Ribeiro RC, Metzger ML, Bhojwani D, Inaba H, Campbell P, Rubnitz JE, Jeha S, Sandlund JT, Downing JR, Relling MV, Pui CH, Howard SC (2015) Utility of early screening magnetic resonance imaging for extensive hip osteonecrosis in pediatric patients treated with glucocorticoids. J Clin Oncol 33:610–615

    Article  PubMed  PubMed Central  Google Scholar 

  25. Smith FE, Sweet DE, Brunner CM, Davis JS (1976) Avascular necrosis in SLE. An apparent predilection for young patients. Ann Rheum Dis 35:227–232

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Vaszilko M, Kovacs E, Restar L, Balla B, Cseplo K, Kosa J, Lakatos P (2014) Potential significance of antiestrogen therapy in the development of bisphosphonate related osteonecrosis of the jaw. J Craniomaxillofac Surg 42:1932–1936

    Article  PubMed  Google Scholar 

  27. Petropoulou AD, Porcher R, Herr AL, Devergie A, Brentano TF, Ribaud P, Pinto FO, Rocha V, Peffault de Latour R, Orcel P, Socié G, Robin M (2010) Prospective assessment of bone turnover and clinical bone diseases after allogeneic hematopoietic stem-cell transplantation. Transplantation 89:1354–1361

    Article  PubMed  Google Scholar 

  28. Jagasia S, Misfeldt A, Griffith M, Jagasia M (2010) Age and total-body irradiation in addition to corticosteroid dose are important risk factors for avascular necrosis of the bone. Biol Blood Marrow Transplant 16:1750–1751

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

AL and SB contributed equally to this manuscript. AL and SB contributed to the data analysis, data interpretation, analysis, and manuscript writing. DK contributed to the design of study, the supervision of data collection and of data interpretation, data analysis, and critical revision of the manuscript. IP, WL, FM, AG, AV, JL, RK, JM, and HM were involved in the supervision of the data collection, interpretation of the data, and critical revision of the manuscript.

Corresponding author

Correspondence to Dennis Dong Hwan Kim.

Ethics declarations

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Law, A.D., Bhella, S., Pasic, I. et al. Moderate-severe grade of chronic graft versus host disease and younger age (less than 45 years old) are risk factors for avascular necrosis in adult patients undergoing allogeneic hematopoietic cell transplantation. Ann Hematol 100, 1311–1319 (2021). https://doi.org/10.1007/s00277-021-04480-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-021-04480-5

Keywords

Navigation